Privia Health (PRVA) EBITDA Margin (2020 - 2026)
Privia Health (PRVA) posted EBITDA Margin of 1.88% for Q2 2026, up 50.31% on a QoQ basis from 1.25% in Q1 2026, and up 121.0% year-over-year from 0.85% in Q2 2025.
Analysis
Privia Health (PRVA) EBITDA Margin (2020 - 2026) Analysis & Trends
Privia Health has reported EBITDA Margin for 7 years, with the latest figure at 1.88% in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 121.0% year-over-year to 1.88% in Q2 2026; TTM through Jun 2026 was 1.93%, a 85.0% increase from a year earlier, with the FY2025 full-year figure at 1.65%, up 61.0% from the prior year.
- EBITDA Margin was 1.88% for Q2 2026 at Privia Health, up from 1.25% in the prior quarter.
- The five-year high for EBITDA Margin was 2.51% in Q3 2025, with the low at 3.58% in Q1 2022.
- Average EBITDA Margin over 5 years is 0.75%, with a median of 1.22% recorded in 2024.
- The largest YoY upside for EBITDA Margin was 8398 bps in 2022 against a maximum downside of 742 bps in 2022.
- Over 5 years, EBITDA Margin stood at 0.7% in 2022, then plunged by 44 bps to 0.39% in 2023, then soared by 205 bps to 1.19% in 2024, then jumped by 78 bps to 2.11% in 2025, then decreased by 11 bps to 1.88% in 2026.
- The last three EBITDA Margin figures came in at 1.88% (Q2 2026), 1.25% (Q1 2026), and 2.11% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.64 Bn | 1.16 Bn | 16.29% |
| 2 | RadNet | 5.80 Bn | 5.37 Bn | 88.08 Mn | 6.34% |
| 3 | Concentra Group Holdings Parent | 4.40 Bn | 4.26 Bn | 192.10 Mn | 18.99% |
| 4 | Privia Health | 2.61 Bn | 2.25 Bn | - | 1.88% |
| 5 | Pediatrix Medical | 2.20 Bn | 1.79 Bn | - | 11.67% |
| 6 | Fresenius Medical Care AG | 2.11 Bn | 1.41 Bn | 1.52 Bn | 9.58% |
| 7 | Progyny | 2.01 Bn | 1.77 Bn | 89.30 Mn | 11.41% |
| 8 | Surgery Partners | 1.87 Bn | 3.08 Bn | 622.10 Mn | 12.03% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.47 Bn | 41.94 Mn | 10.25% |
| 10 | Starling Oncology | 595.78 Mn | 554.69 Mn | 27.17 Mn | -2.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.88% |
| Mar 31, 2026 | 1.25% |
| Dec 31, 2025 | 2.11% |
| Sep 30, 2025 | 2.51% |
| Jun 30, 2025 | 0.68% |
| Mar 31, 2025 | 1.13% |
| Dec 31, 2024 | 1.19% |
| Sep 30, 2024 | 1.39% |
| Jun 30, 2024 | 1.28% |
| Mar 31, 2024 | 0.27% |
| Dec 31, 2023 | 0.39% |
| Sep 30, 2023 | 1.40% |
| Jun 30, 2023 | 1.76% |
| Mar 31, 2023 | 1.81% |
| Dec 31, 2022 | 0.70% |
| Sep 30, 2022 | -1.24% |
| Jun 30, 2022 | -1.47% |
| Mar 31, 2022 | -3.58% |
| Dec 31, 2021 | -6.92% |
| Sep 30, 2021 | -4.97% |